Canada Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
February 25, 2015
101 Pages - SKU: BMI5475637
Countries covered: Canada

Canada Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Supported by strong democratic institutions and a long history of stable political Leadership,Canada is home to the second largest pharmaceutical market in the Americas and one of the largest inworld. We believe that drugmakers will continue to realise considerable rewards, as sales of patentedpharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularlyslow penetration of generics. However, drugmakers will find their interests threatened by the potential for asharp correction in private consumption which has been made increasingly fragile by high household debt,a weaker Canadian dollar and expectations of tightening of credit conditions once the Bank of Canadabegins to raise interest rates.

Headline Expenditure Projections

Pharmaceuticals: CAD22.93bn (USD20.75bn) in 2014 to CAD23.62bn (USD19.68bn) in 2015; +3.0%in local currency terms and -5.2% in US dollar terms. Forecast revised upwards from Q115.

Healthcare: CAD211.92bn (USD191.85bn) in 2014 to CAD220.60bn (USD183.84bn) in 2015; +4.1% inlocal currency terms and -4.2% in US dollar terms. Forecast revised downwards from Q115.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Canada Prescription Drugs reports

Pharmaceuticals in Canada by MarketLine
Pharmaceuticals in CanadaIntroductionPharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...
Canada Pharmaceutical Industry by Aruvian's R'search
Canada Pharmaceutical IndustryThe Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada ...
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022SummaryDuring the forecast period from 2012-2022, the growth of the UC market will be ...
Pharmaceuticals in Canada: ISIC 2423 by Euromonitor International
Pharmaceuticals in Canada: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!